Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD - Milan 2023

Novel treatment strategies for airway diseases: a glimpse into the future

Chair(s): Juan Jose Nieto-Fontarigo, Sebastian Riemann

Session type: Poster session

Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD

Iryna Savelikhina

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Effects of Telaglenastat, a glutaminase inhibitor, on airway inflammation and cellular senescence in Cigarette-smoke exposed mice

Kazuhiro Ito

Poster

Abstract

Silencing TSLP expression with a lung-targeted RNAi molecule suppresses pulmonary allergic inflammation

Tingting Yuan

Poster

Abstract

The corticosteroid-sparring effect of vigorous physical activity - a secondary analysis of a randomised controlled trial

Anders Pitzner-fabricius

Poster

Abstract

COPD and anticoagulant therapy: A retrospective cohort study of 1-year all-cause mortality and risk of hospitalization due to a severe exacerbation of COPD

Bard-emil Vang Gundersen

Poster

Abstract

Effects of acid-suppressive medications in patients with chronic obstructive pulmonary disease: a multicenter study using a common data model

Yeonjeong Heo

Poster

Abstract

The bacterial lysate OM-85 amplifies efficacy of Allergen Immunotherapy (AIT) in allergic patients with asthma and rhinitis

Antonios Christopoulos

Poster

Abstract

Effects of Toll-like Receptor Activation on Airway Responses and Inflammation in Guinea Pigs

Yujiao Xiang

Poster

Abstract

Effects of melatonin in an Asthma-COPD overlap model

Vitorio Crema Scheffer

Poster

Abstract

ALIENTO and ARNASA: Study designs of two randomised, double-blind, placebo-controlled trials of astegolimab in patients with COPD

Christopher E. Brightling

Poster

Abstract

Anamorelin, a ghrelin receptor agonist, inhibited the allergic airway inflammation in mice

Hiroki Bando

Poster

Abstract

Characterization of the ADME profile of tanimilast following administration of an intravenous microtracer combined with a single inhaled dose in healthy males

Michele Bassi

Poster

Abstract

The efficacy of chronotherapy in asthma: an open-label, randomised 3-way crossover trial of inhaled corticosteroids (ICS) in atopic asthma

Ran Wang

Poster

Abstract

PI3K?d inhibition suppresses key disease features in a rat model of asthma

James Pinkerton

Poster

Abstract

Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD

Iryna Savelikhina

Poster

Abstract

A Lung-Targeted RNAi Therapeutics Delivery Platform Compatible With Subcutaneous (s.c.) Administration Mediates Pulmonary RAGE Silencing In Rodents And Nonhuman Primates

David Kasahara

Poster

Abstract

A Clinical-Stage Inhaled RNAi Therapeutic For Pulmonary Inflammation Mediates Durable RAGE Silencing In Nonhuman Primates (NHP)

David Kasahara

Poster

Abstract

Heterogeneity of the lung microbiome influences response to Astegolimab, an anti ST2, in COPD

Koirobi Haldar

Poster

Abstract

Late Breaking Abstract - Efficacy and Safety of Dupilumab for COPD with Type 2 Inflammation Indicated by Elevated Eosinophils

Surya Bhatt

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}